Improving immune checkpoint inhibitors' anti-tumor response and minimizing side effects
byTohoku UniversityMetastatic lymph node targeted immune checkpoint blockade (ICB) elicits strong therapeutic response and ameliorates ICB-induced interstitial pneumonia. Credit: Tohoku Universi
Updated on: January 07,2024
8
Improving immune checkpoint inhibitors' anti-tumor response and minimizing side effects
byTohoku UniversityMetastatic lymph node targeted immune checkpoint blockade (ICB) elicits strong therapeutic response and ameliorates ICB-induced interstitial pneumonia. Credit: Tohoku Universi
Updated on:January 07,2024
8
